Kilitch Drugs (India)
KILITCHNSE

Kilitch Drugs (India)

₹178.60-2.43 (1.34%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
174.02
Today’s high
185.23
52 week low
117.25
52 week high
250.00
Open price
181.82
Previous close
181.03
Live volume
1,48,396
Lower circuit
142.88
Upper circuit
214.32

Fundamentals

Market Cap
₹633Cr
ROE
10.79%
P/E Ratio(TTM)
21.46
EPS(TTM)
8.44
P/B Ratio
2.26
Dividend Yield
0.00%
Industry P/E
33.73
Book Value
79.99
Debt to Equity
0.32
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹90.09
+62.79%
Profit (Cr)
₹14.88
+244.44%
0255075100
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+43%
3Y CAGR+21%
Profit growthValue
1Y (TTM)+46%
3Y CAGR+59%

About

Kilitch Drugs (India) Limited is one of the world's leading and fastest-growing pharmaceutical companies, manufacturing and supplying a broad range of formulations globally. The company embraces purpose-driven leadership to create long-term value beyond financial performance, establishing itself as a significant entity in the pharmaceutical industry. It is committed to achieving sustainable healthcare by optimizing its processes and practices through continuous innovation and sustainable operations. Its extensive research has developed a diverse portfolio targeting chronic and acute treatments, including injectables, ophthalmics, effervescent tablets, and nutraceuticals. With a formidable presence across Asia, Africa, CIS, and Latin America, the company offers a broad product portfolio to suit each country's needs. A key international asset is its Ethiopia Unit, the largest Cephalosporin plant in East Africa, producing tablets, capsules, and injectables.;
CEO/MD
Mukund Mehta
Founded in
1992
NSE symbol
KILITCH

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
63.77%
Retail And Others
36.22%
2026
15
May
Quarterly & Annual Result
Release date

24
Mar
Bonus
Ex date
1:1
Ratio

For every 1 shares you hold, you will receive 1 additional shares
Bonus ratio1:1
Ex date24 Mar ‘26
Record date24 Mar ‘26
Announcement date18 Mar ‘26

18
Mar
Bonus
Announced
1:1
Ratio

For every 1 shares you hold, you will receive 1 additional shares
Bonus ratio1:1
Ex date24 Mar ‘26
Record date24 Mar ‘26
Announcement date18 Mar ‘26
11
Feb
Quarterly Result
Release date
2025
13
Nov
Quarterly Result
Release date
13
Aug
Quarterly Result
Release date

15
Jul
Rights Entitlement
Ex date
2:23
Ratio

2 rights eligible for every 23 existing shares held
Ratio2:23
Offer price₹357.00
Ex date15 Jul ‘25
Record date15 Jul ‘25
Announcement date9 Jul ‘25

9
Jul
Rights Entitlement
Announced
2:23
Ratio

2 rights eligible for every 23 existing shares held
Ratio2:23
Offer price₹357.00
Ex date15 Jul ‘25
Record date15 Jul ‘25
Announcement date9 Jul ‘25
Events calendar
View upcoming events in other stocks